|
1
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao XB and Ren GS: lncRNA
Taurine-Upregulated Gene 1 promotes cell proliferation by
inhibiting microRNA-9 in MCF-7 cells. J Breast Cancer. 19:349–357.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Engreitz JM, Ollikainen N and Guttman M:
Long non-coding RNAs: Spatial amplifiers that control nuclear
structure and gene expression. Nat Rev Mol Cell Biol. 17:756–770.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peto R, Boreham J, Clarke M, Davies C and
Beral V: UK and USA breast cancer deaths down 25% in year 2000 at
ages 20–69 years. Lancet. 355:18222000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin A, Li C, Xing Z, Hu Q, Liang K, Han L,
Wang C, Hawke DH, Wang S, Zhang Y, et al: The LINK-A lncRNA
activates normoxic HIF1α signaling in triple-negative breast
cancer. Nat Cell Biol. 18:213–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eades G, Wolfson B, Zhang Y, Li Q, Yao Y
and Zhou Q: lincRNA-RoR and miR-145 regulate invasion in
triple-negative breast cancer via targeting ARF6. Mol Cancer Res.
13:330–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan M, Li X, Jiang W, Huang Y, Li J and
Wang Z: A long non-coding RNA, PTCSC3, as a tumor suppressor and a
target of miRNAs in thyroid cancer cells. Exp Ther Med.
5:1143–1146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Lu X, Geng Z, Yang G and Shi Y:
lncRNA PTCSC3/miR-574-5p governs cell proliferation and migration
of papillary thyroid carcinoma via Wnt/β-catenin signaling. J Cell
Biochem. 118:4745–4752. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia S, Ji R and Zhan W: Long noncoding RNA
papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3)
inhibits proliferation and invasion of glioma cells by suppressing
the Wnt/β-catenin signaling pathway. BMC Neurol. 17:302017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang S, Ke H, Zhang H, Ma Y, Ao L, Zou L,
Yang Q, Zhu H, Nie J, Wu C and Jiao B: lncRNA MIR100HG promotes
cell proliferation in triple-negative breast cancer through triplex
formation with p27 loci. Cell Death Dis. 9:8052018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu J, Zhang Y, You Q, Fu H, Zhao X, Lu K,
Yan R and Yang D: lncRNA PTCSC3 Alleviates the postoperative
distant recurrence of gastric cancer by suppression of lncRNA
HOXA11-AS. Cancer Manag Res. 12:2623–2629. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang X, Zhang J, Li C, Liu J, Shi Z and
Zhou P: Long non-coding RNA SNHG22 facilitates the malignant
phenotypes in triple-negative breast cancer via sponging miR-324-3p
and upregulating SUDS3. Cancer Cell Int. 20:2522020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Ma HY, Hu XW, Qu YY, Wen X, Zhang Y
and Xu QY: lncRNA H19 promotes triple-negative breast cancer cells
invasion and metastasis through the p53/TNFAIP8 pathway. Cancer
Cell Int. 20:2002020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luo L, Tang H, Ling L, Li N, Jia X, Zhang
Z, Wang X, Shi L, Yin J, Qiu N, et al: LINC01638 lncRNA activates
MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation
in triple-negative breast cancer. Ocogene. 37:6166–6179. 2018.
|
|
20
|
Chen FY, Zhou ZY, Zhang KJ, Pang J and
Wang SM: Long non-coding RNA MIR100HG promotes the migration,
invasion and proliferation of triple-negative breast cancer cells
by targeting the miR-5590-3p/OTX1 axis. Cancer Cell Int.
20:5082020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han J, Han B, Wu X, Hao J, Dong X, Shen Q
and Pang H: Knockdown of lncRNA H19 restores chemo-sensitivity in
paclitaxel-resistant triple-negative breast cancer through
triggering apoptosis and regulating Akt signaling pathway. Toxicol
Appl Pharmacol. 359:55–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zuo Y, Li Y, Zhou Z, Ma M and Fu K: Long
non-coding RNA MALAT1 promotes proliferation and invasion via
targeting miR-129-5p in triple-negative breast cancer. Biomed
Pharmacother. 95:922–928. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang N, Hou M, Zhan Y and Sheng X: lncRNA
PTCSC3 inhibits triple-negative breast cancer cell proliferation by
downregulating lncRNA H19. J Cell Biochem. 120:15083–15088. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li P, Ge D, Li P, Hu F, Chu J, Chen X,
Song W, Wang A, Tian G and Gu X: CXXC finger protein 4 inhibits the
CDK18-ERK1/2 axis to suppress the immune escape of gastric cancer
cells with involvement of ELK1/MIR100HG pathway. J Cell Mol Med.
24:10151–10165. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang Y, Zhang C and Zhou Y: lncRNA
MIR100HG promotes cancer cell proliferation, migration and invasion
in laryngeal squamous cell carcinoma through the downregulation of
miR-204-5p. Onco Targets Ther. 12:2967–2973. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang M, Song Y and Yu L: lncRNA PTCSC3
suppressed cervical carcinoma cell invasion and proliferation via
regulating miR-574-5p. Am J Transl Res. 11:7186–7194.
2019.PubMed/NCBI
|
|
27
|
Wang XM, Liu Y, Fan YX, Liu Z, Yuan QL,
Jia M, Geng ZS, Gu L and Lu XB: lncRNA PTCSC3 affects drug
resistance of anaplastic thyroid cancer through STAT3/INO80
pathway. Cancer Biol Ther. 19:590–597. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai Y, Li Y, Sun B, Wang H, Zhang W, Zhao
Y, Zhao H, Zhang J, Xu J and Wang Y: lncRNA PTCSC3 and lncRNA HULC
negatively affect each other to regulate cancer cell invasion and
migration in gastric cancer. Cancer Manag Res. 12:8535–8543. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong L, Wang H, Wang J, Wei S, Zhang F,
Han J, Liu Y, Ma M, Liu C, Xu Y and Jiang D: lncRNA PTCSC3 inhibits
tumor growth and cancer cell stemness in gastric cancer by
interacting with lncRNA Linc-pint. Cancer Manag Res.
11:10393–10399. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang G, Chi N, Lu Q, Zhu D and Zhuang Y:
lncRNA PTCSC3 Is a biomarker for the treatment and prognosis of
gastric cancer. Cancer Biother Radiopharm. 35:77–81.
2020.PubMed/NCBI
|
|
31
|
Ma J, Fan Z, Tang Q, Xia H, Zhang T and Bi
F: Aspirin attenuates YAP and β-catenin expression by promoting
β-TrCP to overcome docetaxel and vinorelbine resistance in
triple-negative breast cancer. Cell Death Dis. 11:5302020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang K, Zhang M, Yao Q, Han X, Zhao Y,
Zheng L, Li G, Liu Q, Chang Y, Zhang P, et al: The
hepatocyte-specifically expressed lnc-HSER alleviates hepatic
fibrosis by inhibiting hepatocyte apoptosis and
epithelial-mesenchymal transition. Theranostics. 9:7566–7582. 2019.
View Article : Google Scholar : PubMed/NCBI
|
